在心力衰竭中实施最佳治疗的合作计划的推理和设计
Alexander J Blood1,2,3, Ozan Unlu1,2,3,4, John W Ostrominski1,2,3,5
1Accelerator for Clinical Transformation, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Clinical cardiology
|February 7, 2026
概括
在COPILOT-HF研究中,测试了一种远程导航器主导的策略,以改善心力衰竭患者的指导方针导向医学疗法 (GDMT). 这种方法旨在优化所有射出分数的HF治疗,解决缓慢的GDMT吸收问题.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 医疗保健服务研究 医疗服务研究
背景情况:
- 指南导向医学疗法 (GDMT) 对心力衰竭 (HF) 患者提供了显著的临床益处,但它们的采用仍然不够理想.
- 改善GDMT实施的现有策略往往是无效的,资源密集的,或仅仅专注于减少射出分数 (HFrEF) 的HF.
- 迫切需要可扩展的,全面的方法来优化GDMT在整个高频谱的高频,包括高频与保留射出分数 (HFpEF).
研究的目的:
- 评估心力衰竭最佳治疗实施合作计划 (COPILOT-HF) 研究的有效性.
- 为了比较一个远程,导航器领导的,算法驱动的GDMT优化策略与标准的患者和提供者教育.
- 评估GDMT优化在心力衰竭喷射分数的全谱.
主要方法:
- 一个务实的,随机的,开放的标签干预试验设计.
- 实施一个全面的,远程的,导航器主导的,算法驱动的GDMT优化战略.
- 与对照干预的比较,重点是患者和提供者对GDMT的教育.
主要成果:
- 主要疗效终点是3个月后接受最佳HF治疗的患者比例.
- 二次结局包括6个月和12个月的最佳HF治疗率.
- 还将评估卫生资源的利用情况,包括住院和死亡率.
结论:
- 该COPILOT-HF研究将确定远程药剂师领导的药物定位策略的有效性.
- 该战略旨在改善GDMT在整个心力衰竭范围内的实施.
- 这些发现将为优化高频药物治疗提供可扩展的解决方案.
相关概念视频
Heart Failure VI: Adjunct Therapies
368
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
368
Heart Failure II: Pathophysiology
975
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
975
Pathophysiology of Heart Failure
3.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.8K
Heart Failure I: Introduction
924
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
924
Cooperative Allosteric Transitions
8.8K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
8.8K
Cooperative Binding of Transcription Regulators
7.4K
Transcriptional regulators bind to specific cis-regulatory sequences in the DNA to regulate gene transcription. These cis-regulatory sequences are very short, usually less than ten nucleotide pairs in length. The short length means that there is a high probability of the exact same sequence randomly occurring throughout the genome. Since regulators can also bind to groups of similar sequences, this further increases the chances of random binding. Transcriptional regulators form...
7.4K


